Epic Research Weekly Equity Report 26 SEP 2016

YOUR MINTVISORY Call us at +91-731-6642300

26th SEP. 2016

WEEKLY EQUITY REPORT

Our Presence

Epic Research India

411 Milinda Manor (Suites 409- 417)

2 RNT Marg. Opp Cental Mall

Indore (M.P.)

Hotline: +91 731 664 2300

Or give us a missed call at

026 5309 0639

HNI & NRI Sales Contact Australia

Mintara Road, Tarneit, Victoria. Post Code 3029

Phone.: +61 422 063855

HNI & NRI Sales Contact USA

2117 Arbor Vista Dr. Charlotte (NC)

Cell: +1 704 249 2315

Toll Free Number

1-800-200-9454

All queries should be directed to

[email protected]


26th SEP. 2016

TOP FIVE GAINERS AND LOSERS

Symbol LTP % Change Traded

Qty Value

(in Lakes) Open High Low

Prev. Close

RELIANCE 1,101.60 1.16 71,05,725 78,182.87 1,089.00 1,109.45 1,089.00 1,088.95

DRREDDY 3,180.00 0.97 1,55,117 4,918.99 3,169.00 3,186.95 3,150.40 3,149.30

TCS 2,400.00 0.93 9,00,363 21,556.58 2,382.00 2,403.85 2,371.15 2,378.00

HCLTECH 795 0.78 26,05,785 20,831.17 794.65 804 792.4 788.85

HDFC 1,424.00 0.76 13,69,990 19,467.42 1,418.00 1,427.20 1,412.00 1,413.25

Symbol LTP % Change Traded Qty

Value (in Lakes)

Open High Low Prev. Close

AXISBANK 556.45 -5.97 3,02,22,177 1,71,522.94 595.6 596.1 555.7 591.8

ACC 1,613.25 -3.17 2,68,908 4,393.07 1,672.00 1,672.00 1,610.70 1,666.05

AMBUJACEM 258.2 -2.77 22,09,059 5,778.24 266 266 258.15 265.55

LUPIN 1,487.10 -2.72 18,83,166 28,331.10 1,528.95 1,529.80 1,484.00 1,528.65

AUROPHARMA 836.4 -2.4 34,45,219 29,394.26 860.45 862.9 832.35 856.95


26th SEP. 2016

EPIC RESEARCH– ANALYST SPEAKS

STRATEGIES:- If we saw to the last week Nifty range then the market was rangebound, down side it maintain 8775 level but volatility surge due to FED and Bank of Japan meets then again around 8900 it slipped because of maximum addition were seen at 8900 Call and 8800 Put strikes.Now on chart the weekly candle is bullish and it has support at 8750 so near 8800 will be buying opportunity for the target of 8950 9000 with strict stop loss of 8715.

NIFTY DAILY CANDLESTICK CHART


26th SEP. 2016


STRATEGIES: - Bank Nifty facing pressure due to weakness in Private banking space but at the last session of week at higher level Psu banks share also faced profit booking at higher level, on weekly chart it created again doji candle since Bank Nifty moving into rising channel line and last week high 20349 but did not sustain and close below 20K. Since 20500 is very strong resistance for Bank Nifty so sell it around20200-20250 with strict stop loss of 20700 for target 19700 19000.

BANK NIFTY DAILY CANDLESTICK CHART


26th SEP. 2016


Last week GLENMARK Future given out-performance and cross major resistance level also close with positive bias. Last week Stock open on negative side and made a low of 901 but given a good pullback from lower level and close near week high, since last session it rose with rising OI in long side .We may see sharp rise for that it will be good to buy around 930-935 for the target of 960-990 with SL of 910.

GLENMARK FUTURE DAILY CANDLESTICK CHART


26th SEP. 2016


Last week ARVIND future show good strength and cross around 3 months range and made a high of 350.45 but last day of previous week stock show some pressure at higher level and close with bearish candle in daily chart, And stock selling pressure continued at higher levels and spent narrow range during the week. So it’s good we can follow sell on rise strategy. We may see sharp fall for that it will be good to sell on rise around 348-350 for the target of 342-332 with SL of 356.

ARVIND FUTURE DAILY CANDLESTICK CHART


26th SEP. 2016

DAILY MARKET WRAPUP

BUY SCRIPT

SCRIPT LEVEL TGT SL

TITAN 401-403 412 425 392

JET AIRWAYS 537-540 550 560 525

SELL SCRIPT

SCRIPT LEVEL TGT SL

GAIL 394-396 387 376 401

PNB 142-143 137 146


26th SEP. 2016

The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any

responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.

Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up

on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility.

The information given herein should be treated as only factor, while making investment decision. The report does not provide individually

tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and

encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on

the information given in this report, which is in violation of rules and regulations of NSE and BSE.

The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all

estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks

recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views

expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of

the information is the acceptance of this disclaimer. All Rights Reserved.

Investment in equity & bullion market has its own risks.

We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any

financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer

to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our

calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then

Serious Legal Actions can be taken.

DISCLAIMER

Epic Research Weekly Equity Report 26 SEP 2016

Business

Transcript of Epic Research Weekly Equity Report 26 SEP 2016